Impact Biomedical Growth Metrics (2022-2026) | IBO

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) -4.01%-4.07%3.58%-54.54%-54.80%-56.80%-61.01%-14.22%-14.79%
Assets Growth (3y) (Quarter) -27.93%
Assets (QoQ) (Quarter) -1.97%-1.00%-0.62%-0.54%5.85%-56.55%-1.18%-4.94%-4.47%-4.41%-1.83%
Capital Expenditures (QoQ) (Quarter) 140.00%-91.67%
Cash & Equivalents Growth (1y) (Quarter) -50.00%-33.33%199,800.00%65,800.00%-99.85%-98.48%
Cash & Equivalents Growth (3y) (Quarter) 14.47%
Cash & Equivalents (QoQ) (Quarter) -66.67%0.00%100.00%0.00%-34.07%566.67%
Cash from Investing Activities Growth (1y) (Quarter) 0.00%100.36%200.00%0.00%-200.00%
Cash from Investing Activities Growth (3y) (Quarter) 44.22%26.07%37.00%
Cash from Investing Activities (QoQ) (Quarter) -27,400.00%98.55%-175.00%90.91%200.00%0.00%-200.00%
Cash from Operations Growth (1y) (Quarter) 16.33%-19.28%52.47%47.48%-49.18%-127.71%-41.49%-80.26%38.76%110.04%31.96%
Cash from Operations Growth (3y) (Quarter) 8.57%31.48%22.94%
Cash from Operations (QoQ) (Quarter) 54.74%-179.34%27.71%8.46%35.47%-11.32%20.12%-160.00%1.50%30.83%-1.76%11.67%116.15%-568.69%
EBITDA Margin Growth (3y) (Quarter) -1.50M
EBITDA Margin (QoQ) (Quarter) 1.12M
EBIT Growth (1y) (Quarter) -34.40%-21.26%-10.37%3.99%37.90%-4.55%-2,202.99%-31.00%-84.19%15.88%-126.63%
EBIT Growth (3y) (Quarter) -15.41%-2.17%-41.79%
EBIT Margin Growth (3y) (Quarter) -1.50M
EBIT Margin (QoQ) (Quarter) 1.12M
EBIT (QoQ) (Quarter) -18.53%-16.09%22.19%-25.53%-6.94%-5.66%32.31%18.81%-80.03%-2,227.51%96.15%-14.16%17.78%
EBT Growth (1y) (Quarter) -40.30%-20.35%75.96%-17.55%21.14%460.32%-2,049.09%-28.06%-1,523.53%-134.78%-78.72%
EBT Growth (3y) (Quarter) -161.89%-14.68%-39.08%
EBT Margin Growth (3y) (Quarter) -20.34M
EBT Margin (QoQ) (Quarter) 19.68M
EBT (QoQ) (Quarter) -22.40%-436.30%83.81%-32.04%-5.00%-7.14%20.86%11.42%579.75%-739.00%95.28%-1,023.00%89.72%
Enterprise Value Growth (1y) (Quarter) -2.25%-2.31%-2.02%-67.79%-45.07%-1.53%-1.57%231.05%95.69%
Enterprise Value Growth (3y) (Quarter) 1.40%
Enterprise Value (QoQ) (Quarter) -0.42%-0.85%-1.22%0.17%-0.13%-67.40%68.44%79.56%-0.17%9.64%-0.43%
EPS (Basic) Growth (1y) (Quarter) -50.55%46.43%57.02%-932.23%-468.78%457.86%-12,189.90%-10.13%-1,224.56%-305.21%80.00%
EPS (Basic) Growth (3y) (Quarter) -384.05%-57.86%-31.50%
EPS (Basic) (QoQ) (Quarter) -196.28%-55.00%80.46%-67.75%-5.43%-24.36%-369.30%7.57%166.34%-4,370.93%95.79%-1,011.70%89.72%
FCF Margin (QoQ) (Quarter) 0.65M
Free Cash Flow Growth (1y) (Quarter) 16.21%-19.28%52.70%48.32%-48.96%-127.71%-41.49%-80.26%38.76%110.04%31.96%
Free Cash Flow Growth (3y) (Quarter) 8.57%31.48%23.07%
Free Cash Flow (QoQ) (Quarter) 54.74%-180.72%26.89%9.80%35.57%-11.32%20.12%-160.00%1.50%30.83%-1.76%11.67%116.15%-568.69%
Gross Margin (QoQ) (Quarter) 0.02M
Gross Profit (QoQ) (Quarter) 525.00%
Interest Coverage Ratio Growth (1y) (Quarter) 83.22%89.98%12.59%91.29%37.90%-4.55%-966.20%-13.73%-59.91%17.15%73.67%
Interest Coverage Ratio Growth (3y) (Quarter) 44.97%55.72%70.34%
Interest Coverage Ratio (QoQ) (Quarter) -79.09%-7.88%23.73%88.61%-6.94%-840.78%92.40%18.81%-80.03%-9,494.50%99.19%-14.16%6.72%
Net Cash Flow Growth (1y) (Quarter) 760.00%-102.02%200.00%-150.00%1,246.46%-234.50%-68,200.00%-69,300.00%-122.96%114.95%102.50%
Net Cash Flow Growth (3y) (Quarter) -173.24%44.39%166.84%
Net Cash Flow (QoQ) (Quarter) -230.00%98.99%300.00%9,800.00%-201.01%100.50%-200.00%266,700.00%-125.09%-1.79%-1.91%11.82%116.34%-83.00%
Net Income Growth (1y) (Quarter) -40.30%47.36%62.54%-17.55%21.14%460.32%-2,049.09%-28.06%-1,523.53%-134.78%-78.72%
Net Income Growth (3y) (Quarter) -161.89%12.95%-39.08%
Net Income (QoQ) (Quarter) -179.85%-50.54%74.78%-32.04%-5.00%-7.14%20.86%11.42%579.75%-739.00%95.28%-1,023.00%89.72%
Net Income towards Common Stockholders Growth (1y) (Quarter) -50.55%46.43%63.27%-46.42%19.33%465.49%-2,094.33%-32.85%-1,514.40%-134.73%-78.72%
Net Income towards Common Stockholders Growth (3y) (Quarter) -169.65%12.06%-51.49%
Net Income towards Common Stockholders (QoQ) (Quarter) -196.31%-55.00%80.46%-67.73%-5.44%-6.28%22.11%7.59%577.73%-738.10%95.28%-1,023.00%89.72%
Net Margin Growth (3y) (Quarter) -20.36M
Net Margin (QoQ) (Quarter) 19.68M
Operating Income Growth (1y) (Quarter) -34.40%-21.26%-10.37%3.99%37.90%-4.55%-2,202.99%-31.00%-84.19%15.88%-126.63%
Operating Income Growth (3y) (Quarter) -15.41%-2.17%-41.79%
Operating Income (QoQ) (Quarter) -18.53%-16.09%22.19%-25.53%-6.94%-5.66%32.31%18.81%-80.03%-2,227.51%96.15%-14.16%17.78%
Operating Margin Growth (3y) (Quarter) -1.50M
Operating Margin (QoQ) (Quarter) 1.12M
Profit After Tax Growth (1y) (Quarter) -40.30%47.36%62.54%-17.55%21.14%460.83%-2,049.72%-28.06%-1,522.85%-134.61%-78.95%
Profit After Tax Growth (3y) (Quarter) -161.86%13.05%-39.14%
Profit After Tax (QoQ) (Quarter) -179.85%-50.54%74.78%-32.04%-5.00%-7.14%20.86%11.42%580.43%-738.29%95.29%-1,022.54%89.75%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 3.99%-2.07%-2.42%-94.08%-94.39%-95.07%-95.39%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -0.34%-0.69%-0.70%-0.35%-0.70%-93.97%-5.88%-12.50%-7.14%
Return on Assets Growth (1y) (Quarter) 0.00M-1.00-1.00-2.00-2.000.00M0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M-1.00-1.00-1.000.00M1.000.00M
Return on Capital Employed Growth (1y) (Quarter) 351.00-0.01M-0.03M0.08M0.06M0.02M
Return on Capital Employed (QoQ) (Quarter) -91.00-34.0089.00388.00-0.01M-0.02M0.11M-0.02M
Return on Sales Growth (3y) (Quarter) -0.00M
Return on Sales (QoQ) (Quarter) 0.00M
Revenue Growth (3y) (Quarter) -48.08%
Revenue (QoQ) (Quarter) 157.14%
Share-based Compensation Growth (1y) (Quarter) -57.89%71,900.00%
Share-based Compensation (QoQ) (Quarter) -89.47%0.00%-50.00%700.00%17,900.00%
Tax Rate (QoQ) (Quarter) 0.02M
Total Debt Growth (1y) (Quarter) -26.47%187.05%
Total Debt (QoQ) (Quarter) 11.38%2.96%144.52%2.37%